CORC

在结果中检索

CORC

浏览/检索结果: 共17条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Concurrent Albumin-Bound Paclitaxel and/or Carboplatin With Radiation Therapy for the Treatment of Locally Advanced Non-Small Cell Lung Cancer 会议论文
58th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), SEP 25-28, 2016
作者:  Wang, S.;  Sun, X.;  Zhang, H.;  Yu, J.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/31
A randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced mucosal melanoma 会议论文
作者:  Sheng, Xi Nan;  Si, Lu;  Chi, Zhihong;  Cui, Chuanliang;  Li, Si Ming
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/04
Corilagin, an anti-tumor herb medicine, sensitizes paclitaxel and carboplatin by primarily inhibiting glycolysis pathways in epithelial ovarian cancer 会议论文
作者:  Jia, Luoqi;  Jin, Hongyan;  Lv, Minzhi;  Zhao, Naiqing;  Liu, Shaosong
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
BEYOND: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, PHASE III STUDY OF FIRST-LINE CARBOPLATIN/PACLITAXEL (CP) PLUS BEVACIZUMAB (BV) OR PLACEBO (PL) IN CHINESE PATIENTS WITH ADVANCED OR RECURRENT NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) 会议论文
作者:  Zhou, Caicun;  Chen, Gongyan;  Liu, Xiaoqing;  Zhu, Yunzhong;  Lu, Shun
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
Pathological responses and heart safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy in clinical stage II-III, HER2-positive breast cancer patients: A phase 2, open-label, multicentre, randomised trial 会议论文
作者:  Huang, L.;  Chen, S.;  Yang, W.;  Xu, B.;  Huang, T.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19
Phase Ib study of chidamide (CS055), a new subtype-selective oral histone deacetylase inhibitor, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2013-05-20
作者:  Hu, Xing-Sheng;  Shi, Yuan-Kai;  Wang, Lin;  Lin, Lin;  Han, Xiao-Hong
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13
PHASE 2 STUDY COMPARING CISPLATIN/ETOPOSIDE AND WEEKLY PACLITAXEL/CARBOPLATIN REGIMENS WITH CONCURRENT THORACIC RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER 会议论文
EUROPEAN JOURNAL OF CANCER, 2013-03-01
作者:  Liang, J.;  Wang, W.;  Ou, G.;  Hui, Z.;  Lv, J.
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13
Significantly Higher Pathologic Complete Response Rate with Weekly Compared with Three-weekly Paclitaxel and Carboplatin Plus Trastuzumab Neoadjuvant Therapy - Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2-positive Breast Cancer 会议论文
作者:  Shao, Z. M.;  Chen, C. M.;  Zhou, Y.;  Chen, S.;  Hou, Y. F.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
Circulating endothelial cells and serum caspase-cleaved CK18 to predict for response and survival in non-small cell lung cancer patients receiving endostatin and paclitaxel-carboplatin combined chemotherapy. 会议论文
作者:  Chu, Tianqing;  Ding, Hao;  Gu, Aiqin;  Pei, Jun;  Han, Baohui
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19
Phase II study of combination paclitaxel and carboplatin in patients with advanced or recurrent endometrial cancer. 会议论文
作者:  Shan, B.;  Wang, H.;  Ren, Y.;  Tu, X.;  Jiang, Z.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace